Compare AUPH & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUPH | NRDS |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 631.6M |
| IPO Year | 2014 | 2021 |
| Metric | AUPH | NRDS |
|---|---|---|
| Price | $16.96 | $9.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $17.25 | $15.00 |
| AVG Volume (30 Days) | ★ 858.1K | 574.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 68.42 |
| EPS | ★ 0.53 | 0.37 |
| Revenue | $283,055,000.00 | ★ $836,600,000.00 |
| Revenue This Year | $17.54 | $10.13 |
| Revenue Next Year | $15.74 | $7.11 |
| P/E Ratio | $32.00 | ★ $24.92 |
| Revenue Growth | 20.38 | ★ 21.67 |
| 52 Week Low | $10.34 | $7.33 |
| 52 Week High | $19.25 | $16.24 |
| Indicator | AUPH | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 38.64 |
| Support Level | $15.65 | $9.07 |
| Resistance Level | $17.80 | $9.75 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 85.50 | 8.78 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.